Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research & Pathophysiology III1 Apr 2018MP88-15 HIGH ACTIVATION BUT NOT OVEREXPRESSION OF CAMP RESPONSIVE ELEMENT BINDING PROTEIN 1 (CREB1) IS AN FEATURE OF POOR PROGNOSIS IN ADVANCED CLEAR CELL RENAL CARCINOMA Liqun Zhou, Xuesong Li, and Yifan Li Liqun ZhouLiqun Zhou More articles by this author , Xuesong LiXuesong Li More articles by this author , and Yifan LiYifan Li More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2935AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Clear cell renal cell carcinoma (ccRCC) is clinically silent at their earliest stages, therefore, at the time of the initial diagnosis, up to 30% of patients have already progressed to a locally advanced disease state or exhibit metastases. cAMP responsive element binding protein 1 (CREB1) is a proto-oncogene in various cancer. This study was to explore the function and clinical significance of phosphorylated cAMP responsive element binding protein 1 (p-CREB1) at Ser 133 site in advanced ccRCC. The CREB1 phosphorylate pathway may be a novel target for kidney therapy. METHODS The expression of p-CREB1 (Ser133) and non p-CREB1 (Ser133) is determined by immunohistochemistry (IHC) in 151 advanved ccRCC patients. Through constructing lentiviral vector and using small molecular inhibitor, 666-15, the phosphorylated CREB (Ser133) are knockdown, overexpressed and inhibited. The proliferation of 786-0 cells in vitro and in vivo was determined by clone formation assay, MTS assay, and subcutaneous tumor formation in nude mice. To investigate the mechanisms, the interacting proteins of CREB1 were precipitated by pull-down assay and identified by mass spectrum. Then the proteins interaction was confirmed by co-immunoprecipitation in kidney cancer cells. Protein and mRNA expression level were measured by western blot and qPCR, respectively. RESULTS P-CREB1 (Ser133) and non p-CREB1 (Ser133) is highly expressed in ccRCC tissues. In multi-factor regression analysis, p-CREB1 (Ser133) is an independent risk factor but not non p-CREB1. The clone formation and proliferation ability is inbibted by phosphorylated CREB1 (Ser133) knockdown and 666-15, however, reversed by CREB1 (Ser133) overexpression. And subcutaneous tumor in nude mice is significantly shrinked by treating with 666-15.The interaction of CREB1 with serine/threonine-protein kinase 1 (SRPK1) and casein kinase II subunit beta (CSNK2B) were identified and confirmed in kidney cancer cells. The expression of p-CREB1 (Ser133) protein was higher in SRPK1 and CSNK2B overexpressed cells.Knockdown SRPK1 and CSNK2B, the p-CREB1 (Ser133) protein was decreased, the proliferation and migration ability were attenuated, and the cell apoptosis was induced in kidney cancer cells. CONCLUSIONS Highly expressed p-CREB (Ser133) is an independent risk of ccRCC patient. CREB1 was activated by SRPK1 and CSNK2 through phosphorylation. Target CREB1 phosphorylate pathway may inhibit the cancer phenotype of ccRCC. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e1203 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Liqun Zhou More articles by this author Xuesong Li More articles by this author Yifan Li More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Phosphorylation of Camp Response Element Binding Protein in Glioma Cells Induced by Bradykinin

Muscarinic Receptor-Mediated Activation of P70 S6 Kinase 1 (s6k1) in 1321n1 Astrocytoma Cells: Permissive Role of Phosphoinositide 3-Kinase

Muscarinic Receptors Mediate Phospholipase C-dependent Activation of Protein Kinase B Via Ca2+, ErbB3, and Phosphoinositide 3-Kinase in 1321N1 Astrocytoma Cells.

Identification of the Role of TRPM8 in Glioblastoma and Its Effect on Proliferation, Apoptosis and Invasion of the U251 Human Glioblastoma Cell Line

Norepinephrine-Induced Calcium Mobilization in C6 Glioma Cells

In Vitro Effect of TNF-α Expression Induced by Bradykinin in Glioma Cells on the Blood-Tumor Barrier

Knockdown of CREB3 activates endoplasmic reticulum stress and induces apoptosis in glioblastoma.

Bradykinin B1 Receptor Affects Tumor-Associated Macrophage Activity and Glioblastoma Progression

Study of relation between bradykinin-induced blood-tumor barrier opening and TNF-α/MAPK/NF-κB

MP88-15 HIGH ACTIVATION BUT NOT OVEREXPRESSION OF CAMP RESPONSIVE ELEMENT BINDING PROTEIN 1 (CREB1) IS AN FEATURE OF POOR PROGNOSIS IN ADVANCED CLEAR CELL RENAL CARCINOMA

Crebanine, an aporphine alkaloid, induces cancer cell apoptosis through PI3K-Akt pathway in glioblastoma multiforme

CREB Phosphorylation Promotes Nerve Cell Survival

Effects of endoplasmic reticulum stress-mediated CREB3L1 on apoptosis of glioma cells

PROSTAGLANDIN E2 INDUCES THE PHOSPHORYLATION OF CREB AND GABABR2 IN CULTURED RAT ASTROCYTES

Study Of Correlation Between Expression Of Bradykinin B-2 Receptor And Pathological Grade In Human Gliomas

Transcriptional Upregulation of Microtubule-Associated Protein 2 is Involved in the Protein Kinase A-Induced Decrease in the Invasiveness of Glioma Cells

Study of correlation between expression of bradykinin B<sub>2</sub>receptor and pathological grade in human gliomas

Expression of CREBBP and EP300 Associated With Tumor Volume in Patients With Grade-3 Glioma: A Retrospective Analysis

CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway

Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord

Molecular Characterization of AEBP1 at Transcriptional Level in Glioma